Keppra XR approved for partial-onset seizures

Keppra XR (levetiracetam extended-release tablets, from UCB) has been FDA approved for use as an adjunct in partial-onset seizures in patients ≥16yrs of age. Keppra is already available in immediate-release formulations including: tablet, oral solution, and IV injection.

For more information call (866) 822-0068 or visit www.KeppraXR.com.